Armistice Capital, LLC Spruce Biosciences, Inc. Transaction History

Armistice Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.04 - $2.93 $859,040 - $2.42 Million	-826,000 Reduced 27.03%	2,230,000 $6.53 Million
Q3 2023 Nov 14, 2023	SELL	$2.04 - $2.54 $901,680 - $1.12 Million	-442,000 Reduced 12.64%	3,056,000 $6.91 Million
Q2 2023 Aug 14, 2023	SELL	$1.92 - $2.6 $825,600 - $1.12 Million	-430,000 Reduced 10.95%	3,498,000 $7.52 Million
Q1 2023 May 15, 2023	BUY	$1.15 - $3.17 $4.52 Million - $12.5 Million	3,928,000 New	3,928,000 $8.68 Million

15.4M

16.7K

1.1K

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $9.42M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.